Synthesis of drugs

Synthesis of Drugs

  • New or R&D Drugs   Essential Drugs


Intermediate Name D-Ribose; (3R,4S,5R)-5-(Hydroxymethyl)tetrahydro-2,3,4-furantriol; (2R,3R,4R)-2,3,4,5-Tetrahydroxypentanal
CAS Registry Number 50-69-1
Molecularn Formula C5H10O5
Elements Composition C 40.00% H 6.71% O 53.28%
Molecular Weight 150.13245
Source ABCR GmbH & Co.; Acros Organics; AIDP, Inc.; Air Products & Chemicals, Inc.; AisonsChem - Acroyali Qingdao Co., Ltd.; Aldrich; Alfa Aesar; Amresco Inc.; Aslchem International Inc.; Biosynth International, Inc.; Caledon Laboratories Limited; Carbomer; Coleman Chemical Inc.; Davos Chemical Corporation; Fisher Scientific; Fluka; Hangzhou Pharma & Chem Co., Ltd.; ICN Biomedical Research Products; Indofine Chemical Company, Inc.; Isotec Inc.; Kaden Biochemicals GmbH; Lancaster Synthesis Inc.; Mitsubi
Molecular Structure
Synthesis of Please sign in for more information. Join Now
ChemNet is a registered trademark of Zhejiang NetSun Co., Ltd.
Global Chemical Exchange, China Chemical Network and are services of Zhejiang NetSun Co., Ltd.